Bullous pemphigoid
MONDO:0019082Bullous pemphigoid (BP) is the most common form of autoimmune bullous dermatosis.
Also known as: bullous pemphigoid, Old Age pemphigus, Parapemphigus, benign pemphigus, senile dermatitis herpetiformis
55 clinical trials for this condition and its sub-types, 18 tagged with Bullous pemphigoid itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug RAY121 tested for Long-Term control of autoimmune diseases
Disease control By invitation onlyThis study is a long-term extension of an earlier trial, testing the safety of a drug called RAY121 in people with six different immune system disorders, including antiphospholipid syndrome and immune thrombocytopenia. Participants have already completed four doses of RAY121 and …
Phase 1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Scientists hunt for clues to predict blistering disease severity
Knowledge-focused OngoingThis study looks at 50 people with bullous pemphigoid, a skin condition that causes blisters. Researchers want to see if certain proteins in skin samples and blood markers like IgE and eosinophil counts are linked to how severe the disease is. The goal is to find better ways to m…
Sponsor: Istanbul Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC